Edda Sciutto Selected Research

Cysticercosis

12/2019	Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis.
8/2018	Anti-GK1 antibodies damage Taenia crassiceps cysticerci through complement activation.
1/2018	Transplastomic plants yield a multicomponent vaccine against cysticercosis.
12/2017	Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen.
9/2017	Quantitative multiplexed proteomics of Taenia solium cysts obtained from the skeletal muscle and central nervous system of pigs.
5/2017	Transgenic papaya: a useful platform for oral vaccines.
3/2016	Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.
1/2016	Role of porcine serum haptoglobin in the host-parasite relationship of Taenia solium cysticercosis.
12/2013	Immunodiagnosis of porcine cysticercosis: identification of candidate antigens through immunoproteomics.
8/2013	Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edda Sciutto Research Topics

Disease

25	Cysticercosis 12/2019 - 07/2002
12	Neurocysticercosis 01/2021 - 12/2003
11	Infections 12/2019 - 06/2003
9	Cysts 08/2020 - 04/2012
5	Neuroinflammatory Diseases 06/2022 - 02/2012
4	Inflammation (Inflammations) 02/2022 - 06/2003
4	Human Influenza (Influenza) 01/2021 - 05/2014
3	COVID-19 02/2022 - 01/2021
3	Taeniasis 07/2016 - 04/2002
3	Echinococcosis (Hydatid Cysts) 12/2013 - 06/2010
2	Epilepsy (Aura) 10/2021 - 12/2019
2	Parkinson Disease (Parkinson's Disease) 10/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 08/2017
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 01/2017
2	Cestode Infections (Tapeworm Infection) 09/2017 - 08/2007
1	Temporal Lobe Epilepsy 10/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020
1	Ischemic Stroke 10/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Sepsis (Septicemia) 01/2019
1	Shock 01/2019
1	Central Nervous System Cysts (Suprasellar Cyst) 09/2017
1	Intracranial Hypertension 06/2017
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 05/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Multiple Sclerosis 01/2017
1	Communicable Diseases (Infectious Diseases) 12/2014
1	Virus Diseases (Viral Diseases) 05/2014
1	Dengue (Dengue Fever) 12/2012
1	Helminthiasis (Helminthiases) 12/2012
1	Neglected Diseases 12/2012
1	Rabies (Hydrophobia) 12/2012
1	Aneurysm (Aneurysms) 09/2012
1	Zoonoses 02/2011

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2021 - 07/2002
16	Peptides (Polypeptides)IBA 01/2021 - 07/2002
16	AntigensIBA 09/2017 - 07/2002
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2013
6	CytokinesIBA 10/2021 - 06/2003
4	AntibodiesIBA 08/2020 - 06/2003
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 09/2005
3	Protein Subunit VaccinesIBA 02/2007 - 07/2002
2	Methylprednisolone FDA LinkGeneric 06/2022 - 01/2020
2	GlucocorticoidsIBA 02/2022 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022 - 10/2020
2	Pharmaceutical PreparationsIBA 10/2021 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 10/2021 - 09/2005
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2017
2	TubulinIBA 12/2020 - 12/2013
2	Levodopa (L Dopa)FDA LinkGeneric 10/2020 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 08/2020 - 07/2015
2	TropomyosinIBA 09/2017 - 12/2013
2	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2017 - 05/2014
2	Small Heat-Shock ProteinsIBA 12/2013 - 05/2005
2	Subunit VaccinesIBA 05/2007 - 02/2007
2	6,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA 04/2006 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 06/2003 - 11/2002
1	TolueneIBA 06/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	AutoantibodiesIBA 12/2020
1	Pramipexole (Mirapex)FDA LinkGeneric 10/2020
1	EnzymesIBA 08/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Complement C5 (Complement 5)IBA 12/2019
1	TNF Receptor-Associated Factor 1IBA 12/2019
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Capsules (Microcapsules)IBA 08/2018
1	Complement System Proteins (Complement)IBA 08/2018
1	brain synaptic membrane glycoprotein gp 50 (GP50)IBA 09/2017
1	Calcium-Binding ProteinsIBA 09/2017
1	EpitopesIBA 09/2017
1	ProteomeIBA 01/2017
1	Monoclonal AntibodiesIBA 10/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2016
1	HaptoglobinsIBA 01/2016
1	Octoxynol (Triton X 100)IBA 07/2015
1	BuffersIBA 07/2015
1	metaperiodate (periodate)IBA 07/2015
1	Detergents (Detergent)IBA 07/2015
1	3- ((3- cholamidopropyl)dimethylammonium)- 1- propanesulfonate (CHAPS)IBA 07/2015
1	Complex MixturesIBA 07/2015
1	amidosulfobetaine-14IBA 07/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 12/2013
1	14-3-3 Proteins (14-3-3 Protein)IBA 12/2013
1	AnnexinsIBA 12/2013
1	Biological ProductsIBA 04/2012
1	ChromatinIBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	Amino Acids FDA Link 06/2010

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2019
2	Intranasal Administration 10/2020 - 01/2020
1	Intravenous Administration 01/2020
1	Aftercare (After-Treatment) 08/2018
1	Injections 04/2012